• Contact
• About APA
• Site Map

• Psychiatric Practice
  • Addiction Psychiatry
  • Ethics
  • Managing Your Practice
  • Medicare Medicaid
  • Practice Guidelines
  • Quality Improvement
• Education & Career Development
  • Educational Initiatives
  • Lifelong Learning & CME
  • Medical Students
  • Meetings
  • Melvin Sabshin Library & Archives
  • Residents
• Research
  • DSM
  • International Programs
  • Psychiatric Research Report
  • Health Policy Analysis
  • APIRE
  • Practice Research Network and Health Services Research
  • Research Training and Funding
  • Education Fellowships and Training
  • Research Colloquium for Junior Investigators
  • Endowment Campaign
• Advocacy
  • Communications & Public Affairs
  • Financing Health Care
  • Government Relations
  • Multimedia
  • Political Action Committee
• Newsroom
  • Annual Reports
  • APA Member & DB-SA Resources
  • News Releases
• Members Corner

• Home
• Research
• DSM
• DSM-V
• BOT Principles

Principles for DSM-V Task Force and Work Group Members

As part of the American Psychiatric Association’s (APA) concerted effort to avoid conflicts of interest and ensure transparency with the development of DSM-V, the Board of Trustees passed the following principles for appointees to the DSM-V Task Force and Work Groups. These principles were adopted in December 2006.

To become a member of the DSM-V Task Force or a DSM-V Work Group, individuals must meet and abide by the following criteria.

Members of the DSM-V Task Force and DSM-V Work Groups agreed to:

• Serve without remuneration for their services with the exception of the DSM-V Task Force Chair.

• Not serve on a work group with a spouse, domestic partner or first degree family member.

• Receive no more than $10,000 annually in the aggregate from pharmaceutical companies/device makers/ biotechnology companies and similar industry entities for direct services such as consultancies, advisory committee positions, forensic assistance, speakers’ bureau services, etc. (These “industry entities” do not include clinical practices, hospitals, nonprofit organizations, managed care organizations, university-based lectures and similar activities.)

• Not hold stock or shares worth more than $50,000 in the aggregate in pharmaceutical companies/ device makers/ biotechnology companies and similar health-care related commercial ventures or receive more than $10,000 annually in the aggregate in dividends from such sources. Stock and shares held in mutual funds, pension or retirement funds, blind trusts and similar arrangements do not count toward these limits.

• Abstain from participating in any capacity in Industry Sponsored Symposia at an APA annual meeting during their task force and/or work group tenure after 2007.